Central, state teams on way to Global Pharma Healthcare plant after firm recalls eye drop linked to vision loss in US

The US Food and Drug Administration has said in a statement that the Chennai-based company is recalling all lots of Artificial Tears lubricant eye drops distributed by EzriCare, LLC and Delsam Pharma to the consumer level due to possible contamination. To date, there are 55 reports of adverse events including eye infections, permanent loss of vision and a death with a bloodstream infection, it added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/VQChjDw
via IFTTT